Resverlogix to Participate in Leading Scientific Conferences

Presentations will Showcase Research by Resverlogix Scientists, Advancing our Understanding of Epigenetics in Chronic Diseases

CALGARY, Alberta, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the Company”) (TSX: RVX), a world leader in epigenetics or gene regulation, today announces its virtual participation at the following scientific conferences:

Read more at globenewswire.com